CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
002589 Realcan Pharmaceutical Group
- 2.95
- +0.12+4.24%
Market Closed Apr 30 15:00 CST
4.44BMarket Cap226.92P/E (TTM)
3.03High2.82Low534.61KlotVolume2.82Open2.83Pre Close156.75MTurnover3.92%Turnover Ratio210.71P/E (Static)1.50BShares3.6652wk High0.81P/B4.03BFloat Cap2.0652wk Low3.11Limit Up1.37BShs Float23.91Historical High2.55Limit Down7.42%Amplitude1.89Historical Low0.02Dividend TTM2.93Avg Price203.06KlotAsk0.68%Div YieldTTM100Lot Size322.45KlotBid
Realcan Pharmaceutical Group Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 23.66%4.97B | -1.52%4.98B | -15.19%4.69B | -34.60%4.04B | -41.63%4.02B | -5.23%5.06B | -3.59%5.53B | 14.92%6.18B | 38.07%6.89B | 16.63%5.34B |
| Transactional financial assets | ---- | ---- | ---- | ---- | ---- | ---- | 600.00%70M | --120M | --100M | ---- |
| Notes receivable and accounts receivable | 2.01%4.26B | 1.86%4.05B | 8.15%4.51B | 7.62%4.51B | -3.60%4.17B | -7.75%3.98B | -50.09%4.17B | -58.06%4.19B | -63.34%4.33B | -60.81%4.31B |
| -Notes receivable | 90.17%424.36M | -12.90%189.05M | 103.75%531.01M | 167.67%600.58M | 1.89%223.15M | 7.36%217.04M | -39.60%260.62M | -60.04%224.37M | -84.96%219.02M | -72.03%202.16M |
| -Accounts receivable | -2.97%3.83B | 2.71%3.87B | 1.78%3.98B | -1.43%3.91B | -3.90%3.95B | -8.50%3.76B | -50.66%3.91B | -57.95%3.97B | -60.29%4.11B | -60.02%4.11B |
| Other receivables (including interest and dividends) | -8.80%883.52M | -9.83%892.75M | -10.97%1.02B | -24.95%927.41M | -29.02%968.76M | -40.73%990.01M | -40.88%1.14B | -36.68%1.24B | -27.20%1.36B | -11.93%1.67B |
| -Other receivable | ---- | ---- | ---- | -24.95%927.41M | ---- | -40.73%990.01M | ---- | -36.68%1.24B | ---- | -11.93%1.67B |
| Advance payment | -50.20%77.85M | -50.52%48.17M | 115.91%225.52M | 46.04%201.04M | -5.84%156.33M | -49.18%97.37M | -77.63%104.45M | -79.31%137.66M | -78.78%166.03M | -70.11%191.59M |
| Inventories | -29.45%690.05M | -34.34%734.74M | 13.19%892.32M | 5.68%926.48M | 27.17%978.04M | 17.24%1.12B | -43.88%788.33M | -48.77%876.69M | -59.21%769.07M | -53.84%954.51M |
| Receivable financing | 71.69%224.62M | 32.63%320.96M | -35.37%191.04M | -58.38%151.63M | -51.39%130.83M | -16.24%242.01M | 3.33%295.58M | 39.11%364.3M | 17.16%269.15M | 7.88%288.92M |
| Other current assets | -9.13%48.58M | -6.23%46.71M | -6.95%46.39M | -34.08%46.76M | -5.06%53.46M | -16.13%49.81M | -9.61%49.86M | 11.07%70.93M | -60.08%56.31M | -59.08%59.39M |
| Total current assets | 6.42%11.16B | -3.97%11.08B | -4.76%11.57B | -17.99%10.81B | -24.83%10.48B | -9.99%11.54B | -33.61%12.14B | -34.42%13.18B | -35.97%13.95B | -37.99%12.82B |
| Non Current assets | ||||||||||
| Other equity investment | 0.00%5.22M | 0.00%5.22M | 0.00%5.22M | -65.71%5.22M | -65.71%5.22M | -65.71%5.22M | -65.71%5.22M | 0.00%15.22M | 0.00%15.22M | 0.00%15.22M |
| Other non-current financial assets | 9.50%209.61M | 9.50%209.61M | 33.96%191.42M | 33.96%191.42M | 33.96%191.42M | 33.96%191.42M | 20.49%142.9M | 19.88%142.9M | 6.05%142.9M | -5.89%142.9M |
| Investment real estate | -4.06%576.07M | -3.01%587.04M | -1.95%598.31M | -5.22%595.61M | -1.27%600.44M | -3.22%605.26M | 3.06%610.22M | 2.05%628.38M | -4.96%608.14M | -2.93%625.42M |
| Long-term equity investment | -20.83%531.9M | -18.84%531.9M | -25.50%532.03M | 22.57%534.36M | 54.10%671.81M | 50.34%655.39M | 1.11%714.13M | -43.53%435.95M | -41.17%435.95M | -31.75%435.95M |
| Fixed assets | ---- | ---- | ---- | -1.52%1.96B | ---- | -6.57%1.85B | ---- | 11.31%1.99B | ---- | 2.78%1.98B |
| Constru in process | ---- | ---- | ---- | -15.03%279.68M | ---- | 36.14%429.34M | ---- | -49.46%329.13M | ---- | -42.62%315.37M |
| Productive biological assets | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
| Oil and gas assets | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
| Intangible assets | -19.26%428.94M | -20.19%440.89M | -15.42%492.61M | -12.76%516.58M | -14.41%531.29M | -11.51%552.39M | 16.81%582.44M | 19.42%592.17M | 31.11%620.72M | 30.49%624.21M |
| Development expenditure | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Goodwill | 0.00%146.67M | 0.00%146.67M | -0.01%146.67M | -0.01%146.67M | -0.01%146.67M | -0.01%146.67M | -71.55%146.69M | -75.19%146.69M | -76.35%146.69M | -76.35%146.69M |
| Long deferred expense | -25.59%37.23M | -35.66%39.16M | -41.64%41.44M | -41.56%45.98M | -43.89%50.03M | -32.32%60.87M | -38.75%71.01M | -28.73%78.68M | -32.62%89.16M | -28.06%89.93M |
| Deferred tax assets | 14.73%279.22M | 0.60%286.15M | 190.26%287.25M | 249.89%283.71M | 137.80%243.38M | 166.64%284.44M | -16.61%98.97M | -32.77%81.08M | -13.63%102.35M | -13.17%106.68M |
| Usufruct assets | -26.33%4.82M | 113.95%5.39M | 91.78%5.28M | 59.33%5.73M | 37.02%6.54M | -60.95%2.52M | -91.23%2.75M | -92.09%3.6M | -89.68%4.77M | -88.28%6.45M |
| Other non current assets | 14.25%440.36M | 14.08%446.21M | -45.55%345.07M | -46.16%357.43M | -54.61%385.44M | -61.97%391.13M | 76.29%633.79M | 84.82%663.93M | 111.00%849.17M | 163.13%1.03B |
| Total non current assets | -3.77%4.88B | -4.62%4.93B | -8.16%4.85B | -3.63%4.92B | -3.20%5.07B | -6.21%5.17B | -3.90%5.28B | -10.31%5.1B | -8.70%5.24B | -3.71%5.51B |
| Total assets | 3.09%16.04B | -4.17%16.01B | -5.79%16.42B | -13.98%15.73B | -18.92%15.56B | -8.85%16.71B | -26.74%17.43B | -29.10%18.28B | -30.28%19.19B | -30.55%18.33B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 31.85%6.33B | -7.08%6.09B | 76.16%6.51B | 30.48%5.53B | -12.40%4.8B | 70.74%6.56B | -32.50%3.7B | -25.32%4.24B | 11.69%5.48B | -7.81%3.84B |
| Notes payable and accounts payable | -25.67%3.15B | -9.14%3.38B | -53.88%3.26B | -49.55%3.68B | -39.30%4.23B | -51.75%3.72B | -8.84%7.06B | -11.87%7.29B | -28.35%6.98B | -21.21%7.71B |
| -Notes payable | -60.81%590.58M | 34.50%603.38M | -84.88%733.84M | -79.35%1.02B | -67.37%1.51B | -91.30%448.6M | 6.68%4.85B | -2.63%4.93B | -25.66%4.62B | -19.86%5.16B |
| -Accounts payable | -6.25%2.56B | -15.12%2.78B | 14.26%2.52B | 12.64%2.66B | 15.68%2.73B | 28.02%3.27B | -30.93%2.21B | -26.43%2.36B | -33.09%2.36B | -23.78%2.56B |
| Contract liabilities | -26.98%12.81M | -51.81%14.03M | -11.71%24.95M | -13.81%27.31M | -57.76%17.54M | -8.45%29.12M | -74.09%28.26M | -72.97%31.68M | -64.73%41.53M | -81.80%31.8M |
| Advance receipts | --8.33M | --11.1M | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --627.17K |
| Salaries payable | -5.52%16.88M | 6.92%19.15M | 9.04%18.69M | -1.08%18.1M | -17.47%17.87M | -20.92%17.91M | -49.18%17.14M | -53.01%18.3M | -40.15%21.65M | -59.41%22.65M |
| Taxs payable | 35.05%21.84M | 77.60%26.25M | 44.35%24.74M | 13.71%19.77M | -64.05%16.17M | -48.55%14.78M | -84.45%17.14M | -86.76%17.39M | -76.10%44.99M | -84.97%28.73M |
| Other payable (including interest and dividends) | -48.30%190.62M | -39.42%191.99M | -54.88%273.4M | -56.47%278.42M | -46.71%368.69M | -56.68%316.91M | -57.26%606M | -58.31%639.65M | -57.20%691.81M | -58.55%731.62M |
| -Interest payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| -Dividend payable | 0.00%3.94M | 0.00%3.94M | -82.15%3.94M | -89.37%3.94M | -94.12%3.94M | -94.12%3.94M | -93.97%22.09M | -90.64%37.09M | -87.12%67.09M | -87.12%67.09M |
| -Other payable | ---- | ---- | ---- | -54.45%274.47M | ---- | -52.90%312.97M | ---- | -47.05%602.56M | ---- | -46.60%664.53M |
| Non current liabilities due within one year | 1,635.89%156.14M | 2,449.62%156.14M | -71.89%2.95M | -72.45%3.05M | 694.15%8.99M | -26.50%6.12M | 190.81%10.51M | 132.55%11.08M | -81.75%1.13M | -49.17%8.33M |
| Other current liabilities | -54.42%52.74M | -58.29%40.7M | -47.12%42.08M | 10.19%99.71M | 60.97%115.73M | 8.32%97.59M | -56.67%79.57M | -61.52%90.49M | -93.30%71.89M | -69.72%90.09M |
| Total current liabilities | 3.72%9.94B | -7.69%9.93B | -11.80%10.16B | -21.73%9.65B | -28.13%9.58B | -13.69%10.76B | -23.66%11.52B | -22.96%12.33B | -24.79%13.33B | -24.47%12.47B |
| Current liabilities | ||||||||||
| Long term loan | 33.00%358.45M | 25.19%327.08M | 184.89%502.26M | 177.94%326.85M | 982.33%269.5M | 288.80%261.27M | 129.86%176.3M | 64.48%117.6M | -65.89%24.9M | 38.56%67.2M |
| Deferred tax liabilities | 0.85%46.18M | 2.15%48.5M | 26.05%45.1M | 25.29%46.16M | 19.18%45.79M | 17.01%47.48M | 26.77%35.78M | 24.84%36.84M | -54.02%38.42M | -51.44%40.58M |
| Long term deferred income | 197.94%4.72M | 192.55%4.74M | 177.25%4.84M | -11.73%1.55M | -15.09%1.59M | -16.28%1.62M | -26.99%1.75M | -89.91%1.76M | -89.31%1.87M | -88.95%1.93M |
| Lease liabilities | -27.89%3.35M | 392.51%4.12M | 302.48%4.27M | 264.66%4.54M | 53.37%4.64M | -69.39%835.71K | -95.93%1.06M | -96.50%1.25M | -92.04%3.03M | -93.03%2.73M |
| Other non current liabilities | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Total non current liabilities | 28.36%412.7M | 23.53%384.44M | 158.96%556.48M | 140.79%379.11M | 371.32%321.52M | 176.77%311.21M | 47.07%214.89M | -2.48%157.45M | -68.90%68.22M | -42.64%112.44M |
| Total liabilities | 4.52%10.35B | -6.82%10.32B | -8.68%10.71B | -19.68%10.03B | -26.09%9.9B | -11.99%11.07B | -22.98%11.73B | -22.75%12.49B | -25.33%13.4B | -24.68%12.58B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%1.5B | 0.00%1.5B | 0.00%1.5B | 0.00%1.5B | 0.00%1.5B | 0.00%1.5B | 0.00%1.5B | 0.00%1.5B | 0.00%1.5B | 0.00%1.5B |
| Capital reserve funds | -3.53%3.59B | -3.53%3.59B | 1.69%3.59B | 1.86%3.59B | 0.30%3.72B | 0.52%3.72B | 4.82%3.53B | -7.95%3.52B | -2.42%3.71B | -7.83%3.7B |
| Surplus reserve funds | 4.91%167.36M | 4.91%167.36M | 4.42%159.53M | 4.42%159.53M | 4.42%159.53M | 4.42%159.53M | 0.00%152.77M | 0.00%152.77M | 0.00%152.77M | 0.00%152.77M |
| Retained profit | -5.92%291.16M | -5.88%276.99M | 4.67%313.54M | -1.69%305.76M | 2.64%309.47M | 5.15%294.3M | -86.21%299.57M | -85.76%311.01M | -86.09%301.51M | -86.83%279.89M |
| Less:Treasury stock | -81.42%42.86M | ---- | --57.65M | --57.65M | 0.00%230.65M | 0.00%230.65M | ---- | ---- | 0.00%230.65M | 0.00%230.65M |
| Shareholders equity without minority interests | 0.84%5.51B | 1.65%5.54B | 0.41%5.51B | 0.17%5.5B | 0.48%5.46B | 0.75%5.45B | -21.26%5.48B | -26.18%5.49B | -26.48%5.44B | -28.54%5.41B |
| Minority interests | -6.67%179.75M | -17.10%156.83M | -6.33%199.14M | -35.33%195.23M | -45.42%192.59M | -45.00%189.18M | -86.66%212.6M | -86.14%301.9M | -83.83%352.84M | -83.82%344M |
| Total shareholder equity | 0.59%5.69B | 1.02%5.69B | 0.16%5.71B | -1.68%5.69B | -2.32%5.66B | -1.99%5.64B | -33.44%5.7B | -39.77%5.79B | -39.55%5.79B | -40.67%5.75B |
| Total liabilityies and equity | 3.09%16.04B | -4.17%16.01B | -5.79%16.42B | -13.98%15.73B | -18.92%15.56B | -8.85%16.71B | -26.74%17.43B | -29.10%18.28B | -30.28%19.19B | -30.55%18.33B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Tianyuanquan Certified Public Accountants Firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.